TARGETING MET-INDEPENDENT EARLY-RESISTANT LUNG CANCER CELLS EVADING ERLOTINIB BY BH3-MIMETIC ABT-737 TO DISRUPT THE BCL-2/BCL-XL SIGNALING DEPENDENCE
JOURNAL OF THORACIC ONCOLOGY(2011)
Key words
erlotinib,Resistance,Bcl-2,ABT-737
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined